University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.

Ota, H, Mahmoudi, M, Kitabata, H, Torguson, R, Chen, F, Satler, LF, Suddath, WO, Pichard, AD and Waksman, R (2015) Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis. Cardiovasc Revasc Med, 16 (2). pp. 84-89.

Full text not available from this repository.

Abstract

OBJECTIVES: The aim of this study was to compare the safety and efficacy of everolimus-eluting stent (EES), sirolimus-eluting stent (SES), and plain old balloon angioplasty (POBA) for the treatment of SES in-stent restenosis (S-ISR). BACKGROUND: The optimal treatment for drug-eluting in-stent restenosis remains controversial. METHODS: The study cohort comprised 310 consecutive patients (444 lesions) who presented with S-ISR to our institution and underwent treatment with EES (43 patients), SES (102), or POBA (165). The analyzed clinical parameters were the 1-year rates of death, Q-wave myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), definite stent thrombosis (ST) and major adverse cardiac event (MACE) defined as the composite of death, MI, or TLR at 1-year. RESULTS: The three groups were well matched for the conventional risk factors for coronary artery disease except for smoking. The 1-year analyzed clinical parameters were similar in the three groups: MACE (EES=14%, SES=18%, POBA=20%; p=0.65), death (EES=2.3%, SES=6.2%, POBA=6.1%; p=0.61), MI (EES=4.8%, SES=2.1%, POBA=2.5%; p=0.69), TLR (EES=11.9%, SES=12.1%, POBA=24%; p=0.78), and TVR (EES=11.9%, SES=24.8%, POBA=22.2%; p=0.23). There were no cases of definite ST. MACE-free rate was significantly lower in patients with recurrent in-stent restenosis (log-rank p=0.006). Presentation with acute MI, number of treated lesions and a previous history of MI were found to be independent predictors of MACE. CONCLUSIONS: In patients presenting with S-ISR, treatment with implantation of an EES, SES, or POBA is associated with similar clinical outcomes. Patients presenting with recurrent ISR may have a poorer clinical outcome.

Item Type: Article
Authors :
NameEmailORCID
Ota, HUNSPECIFIEDUNSPECIFIED
Mahmoudi, Mm.mahmoudi@surrey.ac.ukUNSPECIFIED
Kitabata, HUNSPECIFIEDUNSPECIFIED
Torguson, RUNSPECIFIEDUNSPECIFIED
Chen, FUNSPECIFIEDUNSPECIFIED
Satler, LFUNSPECIFIEDUNSPECIFIED
Suddath, WOUNSPECIFIEDUNSPECIFIED
Pichard, ADUNSPECIFIEDUNSPECIFIED
Waksman, RUNSPECIFIEDUNSPECIFIED
Date : March 2015
Identification Number : 10.1016/j.carrev.2015.01.004
Uncontrolled Keywords : Everolimus-eluting stent, In-stent restenosis, Plain old balloon angioplasty, Sirolimus-eluting stent, Aged, Angioplasty, Balloon, Coronary, Cohort Studies, Confidence Intervals, Coronary Angiography, Coronary Restenosis, Coronary Stenosis, Drug-Eluting Stents, Everolimus, Female, Follow-Up Studies, Humans, Male, Middle Aged, Multivariate Analysis, Patient Safety, Proportional Hazards Models, Retreatment, Retrospective Studies, Risk Assessment, Sirolimus, Statistics, Nonparametric, Survival Rate, Time Factors, Treatment Outcome
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:31
Last Modified : 17 May 2017 10:31
URI: http://epubs.surrey.ac.uk/id/eprint/828122

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800